1. Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas
   Rashmi R. Shah, 2016, Drug Safety CrossRef
2. Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer
   Hsian-Yu Wang et al, 2016, Oncotarget CrossRef
3. Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia
   Takashi Ogura et al, 2019, Respiratory Investigation CrossRef
4. Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography–tandem mass spectrometry: Application to pharmacokinetic interaction studies
   Hadir M. Maher et al, 2016, Journal of Pharmaceutical and Biomedical Analysis CrossRef